Purpose: CivaTech Oncology Inc. (Durham, NC) has developed a novel low-dose rate (LDR) brachytherapy source called the CivaSheet.
INTRODUCTION
Brachytherapy is an advanced radiotherapy modality that includes use of radioactive sources for cancer treatments. For low-dose rate (LDR) brachytherapy, numerous low-energy photon-emitting sources (commonly 125 I or 103 Pd) have been used for treatment. The American Association of Physicists in Medicine (AAPM) Task Group No. 43 report (TG-43) and its associated updates 1, 2, 3 recommended a formalism to characterize these sources and described the relevant dosimetric parameters in detail. There have been advances in source geometry and design since the publication of the report 4, 5, 6, 7, 8 to improve upon the conformity of the delivered dosimetric distributions, such as the CivaString TM , OptiSeed TM , RadioCoil TM , and SmartSeed TM brachytherapy sources. A novel LDR brachytherapy source has been developed by CivaTech Oncology, Inc (Durham, NC) called the CivaSheet. TM The CivaSheet is a planar source array consisting of discrete 103 Pd source elements called the CivaDots which are directional in nature. A gold shield is present in each CivaDot in proximity to the active source region, imparting directionality to the radiation output of the device. A directional source can potentially improve the therapeutic ratio for a given brachytherapy treatment when compared to conventional sources, by selectively targeting diseased tissue and sparing the surrounding healthy structures. Previous investigations 9, 10 reported reduction in dose to normal tissue in breast and prostate cancer treatments when comparing directional to conventional interstitial sources. The manufacturer, CivaTech Oncology, has been developing the device and investigating its efficacy for pancreatic, abdominopelvic, and colorectal cancer treatments (trials NCT03109041, NCT02 843945, NCT02902107) among other sites.
The CivaSheet is unique in design and varies significantly from conventional LDR brachytherapy sources, and therefore, a thorough investigation needs to be performed to ascertain the dosimetric characteristics of the device prior to its clinical use. For conventional LDR sources, guidelines and dosimetric formalisms have been recommended by the AAPM. 2, 11, 12, 13 There is currently no standard protocol for calibration or quality assurance of planar or directional LDR sources. The existing TG-43 formalism needs to be adapted to accommodate the directional CivaDot source. Previous work by Aima et al. 14 addressed the source strength determination for a CivaDot by performing primary air-kerma strength (S K ) measurements. Rivard 15 published the CivaDot dose distribution results as predicted by Monte Carlo simulations. Cohen et al. 16 investigated the suitability of Rivard's results for clinical commissioning of the CivaSheet. This work aims to help in the dosimetric characterization of the CivaDot by performing inphantom measurements and Monte Carlo simulations as well as investigate the repeatability and reproducibility of the source strength standard for the CivaDot.
An intercomparison of two free-air chambers was performed, namely, the University of Wisconsin VariableAperture Free-Air Chamber (UW VAFAC) 17 which is a research instrument, and the National Institute of Standards and Technology Wide-Angle Free-Air Chamber (NIST WAFAC), 18 which is the U.S. primary standard for S K determination of low-energy photon-emitting LDR sources. The intercomparison was performed to facilitate the establishment of a national primary source-strength standard for the CivaDot. Previous primary S K measurements have been performed using the UW VAFAC. 4, 14, 17, 19 The air-kerma strength definition as recommended by TG-43 protocol was adapted to accommodate directional sources as reported previously. 14 The intercomparison consisted of three investigations, first, comparing the NIST-measured CivaDot energy spectrum to the UW-predicted spectrum, second, contrast the CivaDot sourcespecific correction factors for the two free-air chambers, and finally, compare the S K determined for eight CivaDot sources.
This work proposes an element-based approach to characterize the CivaSheet dose distribution, in accordance with previous work by Colonias et al. 20 and Yang et al. 21 for conventional 125 
I and 131
Cs source arrays. In order to do so, the dosimetric characterization of a CivaDot needs to be performed. An investigation was conducted to study the dose distribution of the source in phantom. The dose-rate constant analog for the CivaDot was determined using thermoluminescent dosimeters and Gafchromic EBT3 film in a polymethylmethacrylate (PMMA) phantom. Another experiment was performed with a stack of EBT3 films placed in a custom PMMA phantom to study the CivaDot dose distribution at different depths. The CivaDot source along with the experimental setup was modeled in the Monte Carlo n-Particle Transport Code 6 v1.0 (MCNP6) and simulations were performed to generate various correction factors and provide a comparative basis for the measurements. The purpose of this work is thus to ascertain the dosimetric characteristics of a new directional LDR brachytherapy source called the CivaDot using a variety of measurements and Monte Carlo simulations.
MATERIALS AND METHODS

2.A. Source description
The CivaDot source is comprised of a cylindrical organic polymer capsule encased within a bioabsorbable membrane. The polymer capsule consists of a 103 Pd region, a gold shield (which helps define the "hot" and the "cold" side of the device), and is sealed with epoxy. Figure 1(a) is an illustration of the CivaDot which has been adapted from Aima et al., 14 accounting for a slight change in the bioabsorbable membrane orientation. The CivaSheet and other CivaDot specifications have been published in previous works. 14, 15 For this work, the reference plane was defined as the bottom of the palladium region in the device and the origin was defined as the intersection of the reference plane and the cylindrical axis of the CivaDot. Figure 1(b) is an illustration of the coordinate system used for CivaDot dosimetry for this work. 1,2,3 established a formalism for the dosimetric characterization of conventional LDR brachytherapy sources. These traditional sources were cylindrically symmetric and had isotropic azimuthal emission. The TG-43 report proposed the following dosimetric formalism:
where _ Dðr; hÞ is the absorbed dose-rate-to-water in water at distance r and angle h from the source, S K is air-kerma strength of the source, measured as the averaged source strength on the transverse axis of the source in vacuo at 1 m, Λ is the dose-rate constant, defined as the ratio of absorbed dose-rate-to-water at 1 cm to the S K on the transverse axis of the source, and G X (r,h), g X (r), F(r,h) are the geometric, radial, and two-dimensional anisotropy function, respectively.
In the case of the CivaDot, the directional as well as planar nature of the source array renders the direct application of the TG-43 protocol inappropriate. The definitions of S K , Λ, G X (r,h), g X (r), and F(r,h) were adapted to accommodate this source, and analogous dosimetric parameters were defined for the source. CivaDot S K was defined as a static on-axis (source cylindrical axis) measurement, 14 Λ, G X (r,h), g X (r), and F(r,h) were all defined on the source cylindrical axis considering the directionality of the CivaDot. A point source was assumed for the geometry function.
2.B. Monte Carlo simulations
The CivaDot was modeled in the Monte Carlo transport code MCNP6 22 using source details including material specifications, device dimensions, and schematics provided by CivaTech Oncology. The source was simulated in various geometries including:
• A full UW VAFAC model with the CivaDot in its measurement position
• The source in a PMMA phantom with (a) TLD microcubes, (b) EBT3 film
• The source in a PMMA phantom with an EBT3 filmstack phantom
• The source in a water phantom.
The updated low-energy photon cross section data library (mcplib12) was used for the simulations. The 103 Pd photon spectrum from the National Nuclear Data Center online NUDAT 2.6 database 23 was used. A *F4 tally 22 was used for absorbed-dose calculations, with energy fluence modified by l en /q values. The modified *F4 tally is a collision kerma tally and can be used as an approximation for the absorbed dose. 2 A minimum of 10 9 histories were used for each simulation. The dosimeters were modeled as per manufacturer's specifications, and photon mass energy absorption cross sections were used from the NIST XCOM database. 24 The photon transport cutoff was set to 100 eV. As described in the previous publication, 14 the amount of 103 Pd material present in the active palladium region of the source can be of variable loading based on the specific activity of the material available and the prescription dose. This was referred to as palladium loading. All Monte Carlo simulations for this work assume a palladium loading of 50%, that is, the 103 Pd region is uniformly filled with 50% palladium material and 50% epoxy by mass, with a net density of q = 1.9987 g cm
À3
. The variation in calculated results due to palladium loading is addressed in the uncertainty section.
2.C. Primary S K measurements and free-air chamber intercomparison
The UW VAFAC is a research instrument at the University of Wisconsin-Madison. It is a large-volume free-air chamber that has been used to perform primary S K measurements of various photon-emitting LDR brachytherapy sources. 4, 14, 17, 19 The CivaDot measurement setup when using the UW VAFAC was explained in detail by Aima et al. 14 The UW VAFAC has five interchangeable brass aperture sizes. This work used the UW VAFAC Aperture No. 2 which collimates the radiation emitted from the source into a cone with a half angle of 7.6 ∘ . This aperture has the same collimating solid angle as the NIST WAFAC aperture, which was the other free-air chamber used in this study. The NIST WAFAC is the U.S. national primary standard for low-energy photonemitting brachytherapy sources. 18 Both free-air chamber measurements were performed with the CivaDot held in a static holder and the source cylindrical axis transverse to the aperture plane (hot side of the source facing the primary aperture). An intercomparison of the CivaDot primary S K determination was performed using the two free-air chambers for eight CivaDot sources. This intercomparison provides us with an estimation of the repeatability and reproducibility of the CivaDot S K measurements. 2.C.1. CivaDot energy spectrum comparison As reported previously, 14 the presence of a gold shield (in proximity to the radioactive part of the source) alters the energy spectrum of the CivaDot in comparison to conventional LDR 103 Pd brachytherapy sources. For the purpose of S K determination, NIST measures the source energy spectrum using a high-purity germanium detector with appropriate detector response correction factors. This measured spectrum was compared to UW-calculated CivaDot energy spectrum using MCNP6 simulations assuming a palladium loading of 50%. Since the Monte Carlo resolution is higher than the detector resolution, the MC-predicted spectrum was consolidated into energy bins corresponding to the NIST-measured spectrum. A comparison of the spectra was performed and the presence of the gold fluorescence was investigated.
2.C.2. CivaDot source-specific correction factors for free-air chamber measurements
The CivaDot source-specific correction factors were also compared for the two free-air chambers. A detailed description of the correction factors that need to be determined for the free-air chambers was given by Seltzer et al. 18 and Culberson et al. 17 NIST determines the correction factors for the WAFAC using a combination of empirical, analytical, and MC methods as described by Seltzer et al. 18 For the UW VAFAC, the correction factors were calculated for Aperture No. 2 using Monte Carlo methods (MCNP6 code) as outlined by Culberson et al. and Aima et al. 14, 17 Although these are two different free-air chambers, the comparison provides a good accuracy check for the corrections as the methods used are completely different and are both sensitive to low-energy gold fluorescence observed in the CivaDot energy spectrum.
2.C.3. Primary S K measurements performed without the presence of an aluminum filter
The use of an aluminum filter when performing a primary S K measurement was recommended by the TG-43 report 2 to exclude the titanium fluorescence present in conventional LDR sources. However, the CivaDot does not contain a titanium encapsulation and the magnitude of the correction for the aluminum filter attenuation, k foil , is sensitive to the lowenergy photons which include the fluorescence observed from the gold shield. An additional investigation was performed with the UW VAFAC to study the impact of the aluminum filter on the CivaDot S K determination. The aluminum filter was removed from the UW VAFAC, and CivaDot S K measurements were performed. These measurements were compared to NIST-determined S K values for the same sources using the WAFAC with the presence of an aluminum filter.
2.D. Dose-rate constant analog determination
A polymethyl methacrylate (PMMA) phantom was designed to perform dose-to-water measurements of the CivaDot using thermoluminescent dosimeter microcubes (TLDs) and Gafchromic EBT3 films manufactured by Ashland Inc. (Convington, KY). Figure 2 illustrates the PMMA phantom design for measuring the dose-rate constant (DRC) analog for the CivaDot using TLDs. These measurements were performed in a PMMA phantom of dimensions 20 9 20 9 12 cm 3 . The TLD microcubes used were TLD-100 model (LiF:Mg,Ti) manufactured by Thermo Fisher Scientific Inc. (Waltham, MA). The source was placed in the center of the phantom, and nine TLD microcubes were irradiated along its central axis at a distance of 1 cm on the hot side of the source. The nine TLD microcubes were placed side-by-side in a 3 9 3 9 1 mm 3 slot in the phantom, which was centered on the source long axis. For conventional brachytherapy sources, this measurement is usually performed on the source transverse axis. Dose-to-water measurements were also performed using an EBT3 film for five CivaDot sources in the PMMA phantom using a different insert. The EBT3 film was placed on top of a PMMA slab and the film edges were secured using Kapton tape. The setup was similar to the TLD measurements, with a 3 9 3 cm 2 segment of EBT3 film placed at 1 cm away from the source along its central axis.
2.D.1 TLD microcubes
TLDs were annealed using the standard University of Wisconsin-Madison Medical Radiation Research Center (UWMRRC) protocol. The dosimeters were read out using a Harshaw 5500 automated reader (Thermo Fisher Scientific, Inc., Waltham, MA). Additional details about TLD annealing and readout are provided by Nunn et al. and Reed et al. 25, 26 The dose-rate constant analog for the CivaDot using TLD measurements in a PMMA phantom can be determined with the application of Equation (2):
where the notation is ðX material Þ Source Medium , D is dose, M is charge reading, k is 103 Pd decay constant, t 1 , t 2 are start and stop irradiation times, respectively, CR is the calibration ratio, IEC is the intrinsic energy correction, and PDC refers to the phantom/detector correction. The dose and the charge reading components of this equation can be described as:
• ðM TLD Þ CivaDot phantom refers to the in-phantom measurement.
•
is the calibration ratio.
Þ refers to the intrinsic energy correction.
Þ is the phantom/detector correction.
Various correction factors have to be calculated to determine the CivaDot DRC analog. The phantom/detector corrections were calculated using MCNP6 simulations of the measurement geometry and a water phantom. For the TLD measurements, additional TLD microcubes were irradiated using a 60 Co beam to relevant dose-to-water values for calculating the TLD calibration coefficient (cGy/nC). Since there is no consensus DRC analog value for the CivaDot, the most appropriate intrinsic energy correction values for the TLD measurements are the NIST-matched x-ray beam M40 (effective energy: 19.2 keV, 40 kVp) value reported by Nunn et al. 25 and the 103 Pd Best LDR seed Model 2335 value reported by Reed et al. 26 An average of the valued reported by Nunn et al. and Reed et al. was used. The DRC analog was determined for eight CivaDot sources using TLDs in phantom.
2.D.2 EBT3 film
The CivaDot dose-rate constant analog was also measured using EBT3 film. The next section describes the calibration procedure and other associated details for the EBT3 film measurement. Equation (2) was adapted for the EBT3 film measurements, and the related correction factors were determined using MCNP6 simulations of the CivaDot source in the measurement setup and in a water phantom. The DRC analog was estimated using the film measurements by evaluating a region-of-interest (ROI) of the same size as the TLDmicrocube setup slot, 3 9 3 mm 2 . A comparison of the two dosimeters was performed to evaluate the accuracy of an individual dosimeter and also demonstrate the applicability of using EBT3 film for further characterization of the CivaDot dose distribution. The DRC analog for the CivaDot was then determined for eight sources using EBT3 film.
2.E. CivaDot dose distribution measurements using a film stack phantom
A PMMA phantom was designed to perform dose measurements of the CivaDot using Gafchromic EBT3 films at multiple depths. Figure 3 is an illustration of the PMMA phantom, 20 9 20 9 12 cm 3 , used for these measurements. The CivaDot source was placed in the center of the phantom and six EBT3 films with dimensions, 12 9 12 cm 2 , were irradiated simultaneously along its central axis at various depths. Five EBT3 films were placed on the hot side of the source at distances of 1, 2, 3, 4, 5 cm and one on the cold side of the source at a distance of 0.5 cm. For conventional brachytherapy sources, this measurement is usually performed on the source transverse axis. Measurements were performed for three CivaDot sources using the EBT3 film stack setup.
2.E.1. EBT3 film calibration and readout
The EBT3 film dosimeters were read out using an EPSON (Nagano, Japan) 10000XL flatbed scanner. Two days prior to each in-phantom measurement, the required EBT3 film was cut from the same batch. The cropped films were prescanned 6 h before an exposure along with a set of NIST-traceable optical density (OD) filters (Kodak Wratten TM No. 96 polyester neutral density filters). The measured OD values of the NIST-traceable OD filters [individual pixels converted to optical density using a -log(pixel value/65535) function] were compared to their actual OD values for every film readout 
OD values of the film dosimeters read out were then mapped back to their traceable OD values using the linear fit obtained with the filters. This process mitigates some of the instrument variability between scans as the actual optical density of the filters can be assumed to vary negligibly during the measurements. The films were then read out along with the filters a week after a CivaDot irradiation was performed. Two background films were also used for each measurement, and their net optical density was subtracted from the measured optical density. A calibration curve was determined for the film measurements by irradiating additional films using a NIST-matched M40 x-ray beam (effective energy:19.2 keV, 40 kVp). A total of 62 dose-to-water values were used for the calibration curve, with four films irradiated for each dose. The relevant exposure times for the M40 x-ray beam were calculated using a NIST-traceable ionization chamber measurement of the beam air-kerma, and then using a Monte Carlo estimated air-kerma to dose-towater conversion ratio. Methods outlined by Hammer et al. 27 were followed for the calibration procedure. Figure 4 shows the results of the calibration. A cubic polynomial fit was used to assess the calibration dose value and the measured net optical density relationship. The CivaDot source and the phantom setup were modeled using the MCNP6 code. The phantom/detector corrections were calculated using MCNP6. The intrinsic energy correction value for this measurement was assumed to be unity based on the findings of Morrison et al. and Chiu-Tsao et al. 28 ,29
2.E.2. Film analysis
The postscanning analysis was performed using MATLAB software version R2016a developed by Mathworks Inc. (Natick, MA). The red-channel values were used for all analysis, as the red channel is most sensitive to doses in the range of interest. 30 Once a film was scanned, the individual pixel values were converted to traceable OD filter values, and finally, the net OD values for a given film were calculated by subtracting its pre-exposure OD value and the background film OD change from the postexposure OD value. The net OD values were then converted to absolute dose-to-water values using the calibration curve.
2.E.3. Dose difference maps and other TG-43 analog parameters
The measurement setup was simulated using MCNP6. Phantom/detector correction factors were calculated using MC methods. The measured dose distribution values obtained for a given film in phantom were converted to doserate to water values. The measured values at different depths were compared to the MC-predicted dose distributions at those depths. This comparison was performed using a dose difference map, whereby each pixel of the simulated CivaDot dose distribution was subtracted from the measured CivaDot dose distribution. TG-43 analog dosimetric parameters such as radial dose function analog and 2D anisotropy function analog were also assessed for the measured and the simulated dose distributions. For analysis, an ROI of AE0.25 mm was set around the relevant dose distribution to calculate a dosimetric parameter.
RESULTS
3.A. NIST WAFAC and UW VAFAC intercomparison
3.A.1. CivaDot energy spectrum comparison Table I shows the results of the comparison of the CivaDot-measured energy spectrum as provided by NIST using a HPGe detector to the energy spectrum calculated for this investigation using MCNP6 simulations of the CivaDot. The measured and the predicted spectrum were normalized to the net counts, yielding relative intensities. Three additional photopeaks were observed in both the measured and the predicted CivaDot energy spectrum when compared to a conventional 103 Pd seed spectrum. These spectral peaks (9.7, 11.4, 11.7 keV) correspond to the gold shield fluorescence observed in the source spectrum. All seven photopeaks for the measured and the predicted spectra agreed to within 1.8%.
3.A.2. UW VAFAC correction factors
The correction factors for a CivaDot UW VAFAC Aperture No. 3 were determined by Aima et al. 14 Following the same methods, source-specific correction factors for the CivaDot measurement using the UW VAFAC Aperture No. 2 were calculated for this work. These factors were calculated using Monte Carlo as outlined in previous publications. 14, 17, 19 NIST determined the source-specific correction factors for the WAFAC CivaDot measurements by applying a combination of empirical, analytical, and MC methods as outlined by Seltzer et al. 18 Table II provides the results of the comparison. The CivaDot net correction factor for the two free-air chambers agreed to within 0.7%.
3.A.3. CivaDot S K measurements
A comparison was performed of the S K determination of eight CivaDot sources using the two free-air chambers, as shown in Table III . The S K determined using the UW VAFAC was within 1.1% of the NIST WAFAC values for all eight CivaDot sources with comparable uncertainties and an average difference of 0.3%.
3.A.4. Impact of the aluminum filter on the CivaDot S K measurements
The impact of the aluminum filter on the UW VAFAC determined CivaDot S K is shown in Table IV . The CivaDot S K determined using the UW VAFAC without the aluminum filter when compared to WAFAC determined values with the presence of an aluminum filter resulted in an agreement to within 0.5% for all three sources measured. There was a noticeable difference in the uncertainty associated with the measurements. The UW VAFAC uncertainty reduced from 1.8% to 1.1%. 
3.B. CivaDot dose-rate constant analog results
3.C. Film stack measurements
The dose rate-to-water distribution normalized to airkerma strength of a CivaDot measured at a distance of 1 cm (hot side) from the source is shown in Fig. 5(a) . For analysis, the dose-rate distributions normalized to S K of all three CivaDot sources measured in-phantom using EBT3 film were compared to the MCNP6 predicted dose-rate distribution normalized to S K at all the six depths. Figure 6 presents the results of the x-profile and the y-profile for the three CivaDot sources measured in-phantom at the 1 cm plane (hot side) as well as the MCNP6 prediction. Figure 5(b) shows the results of the pixel-by-pixel difference map of the measured and predicted dose distribution of the source at 1 cm depth. As observed in the figure, most differences were within 2-3%, with maximum differences up to 5%. On the cold side of the source, the EBT3 measured dose distribution at 0.5 cm agreed with the MC-predicted distribution to within 3.5% of the prescribed dose at 1 cm depth.
3.C.1. CivaDot radial dose function analog results
The radial dose function (RDF) analog was determined for the source based on TG-43 protocol definition adapted to an on-axis definition considering the directionality of the CivaDot. Figure 7 and Table VI present the results of the measured RDF analog and the Monte Carlo-predicted RDF analog. Good agreement was observed at 2 cm depth (within 6.3%), with a divergence at deeper depths. On the cold side of the source, the EBT3-measured RDF analog at the depth of 0.5 cm was 0.0462 and the MC-predicted RDF analog was 0.0394.
3.C.2. CivaDot 2D anisotropy function analog results
Since the measurement setup utilized a stacked geometry, the cylindrical nature of the 2D anisotropy function limits the number of measured data points that can be used for a comparison with Monte Carlo simulations. An ROI of 0.5 mm was set around the intersection of a given polar angle with the film stack planes at set radii. Table VII presents the results of this comparison. Good agreement was observed between the measured and predicted F(r,h) (≤6.5%) for distances up to 3 cm.
UNCERTAINTY
The combined (Types A and B) relative standard uncertainty associated with UW VAFAC CivaDot measurements of 103 Pd sources was provided in detail by Aima et al. 14 Taking the palladium loading into account, the relative standard uncertainty for the UW VAFAC S K measurement with CivaDots is estimated to be ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi r 2 rep þ 0:75 2 þ 1:62 2 q %, where r rep is the reproducibility of the free-air chamber measurements as defined by Culberson et al. 17 The Monte Carlo simulation uncertainty budget is presented in Table VIII for CivaDot DRC analog and RDF analog determination. The Type B uncertainty associated with the simulations was based on the works of Reed et al. 4 , Rivard 15 , Aima et al. 14 The Type A tally statistics were within 1% for all simulations. An additional component of palladium loading was added as an uncertainty in Monte Carlo-predicted TABLE III. The air-kerma strength intercomparison results for eight CivaDots using NIST WAFAC and UW VAFAC. The standard uncertainty ('u') for the UW VAFAC was calculated as outlined by Aima et al. [14] , and for the NIST WAFAC by Seltzer et al. [18] . values. Dose to water and air-kerma strength simulations were performed with palladium loading of 20% and 80% and a rectangular distribution was assumed for the uncertainty determination. For the Monte Carlo-predicted anisotropy data, uncertainties similar to the RDF analog were observed expect for the palladium loading component. The variation due to palladium loading for the 2D anisotropy function can vary as much as 25% at deeper depths.
The uncertainty associated with measurements performed in phantom using TLD microcubes for CivaDot DRC analog determination is presented in Table IX . Typical University of Wisconsin Radiation Calibration Laboratory (UWRCL) uncertainties were assumed for this budget. For EBT3 film measurements, an uncertainty estimation is provided in Table X . The Type A standard deviation of various regions of interest during data analysis was within 1.5%. The source positioning uncertainty for the measurements was estimated to be within AE50 lm. The positioning uncertainty for the EBT3 film and TLD measurements was estimated to be within AE100 lm. The associated uncertainties were calculated using relevant Monte Carlo simulations of the measurement setup and reported in the uncertainty budget of the respective measurements.
DISCUSSION
An intercomparison of the S K determined for eight CivaDot sources was performed using the UW VAFAC and the NIST WAFAC. The CivaDot energy spectrum was measured by NIST and compared to UW Monte Carlo-predicted spectrum. Good agreement was observed in the spectral comparison (≤1.8%), especially considering the fact that the Monte Carlo simulations assume a fixed palladium loading. This comparison also validates previous findings published by Aima et al. 14 Gold fluorescence was observed in both the spectra which contribute significantly to the S K measurement of a CivaDot. A comparison of the S K determined using the UW VAFAC agreed to within 1.1% of the NIST WAFAC values for all eight CivaDot sources with comparable uncertainties and an average difference of 0.3%. These results illustrate the good repeatability of the UW VAFAC and NIST WAFAC results and comparable reproducibility of the UW VAFAC measurement to the U.S. national standard. The free-air chamber source-specific correction factors for the CivaDot for the two instruments were comparable. The net correction factor using the two methods was in good agreement (0.7%) as seen in Table II , considering the fact that these are two different free-air chambers. It is also a validation of determining the correction factors using two distinct methodologies. NIST utilizes a combination of empirical, analytical, and MC methods approach whereas UW calculates the factors using Monte Carlo methods. It is apparent that the aluminum filter correction is the largest contributor to the overall correction. The aluminum filter attenuates the gold fluorescence present in the CivaDot energy spectrum considerably for both free-air chambers. The use of an aluminum filter for S K measurement was recommended by the TG-43 report 2 for the exclusion of titanium fluorescence present in conventional LDR sources. However, the CivaDot does not contain a titanium encapsulation and the correction for the aluminum filter attenuation, k foil ,is about 1.14-1.15 for the CivaDot compared to about 1.08 for a conventional 103 Pd brachytherapy source. Although a larger correction does not lead to inaccurate results, the UW VAFAC uncertainty for the measurements takes into account the palladium-loading impact (source self-shielding). The intensity of the gold fluorescence changes with the amount of palladium loading. This impacts the k foil factor and once the aluminum filter is removed, this source of uncertainty is mitigated. It was found that the UW VAFAC uncertainty decreases by a factor of about 0.4 as the effect of palladium loading on correction factor uncertainty diminishes.
Dose distribution measurements of the CivaDot were performed using TLD microcubes and EBT3 film in a PMMA phantom for eight CivaDot sources to determine the dose rate constant analog. The source dose distribution was also predicted by using Monte Carlo simulations. Good agreement was observed between the two dosimeters and Monte Carlo-predicted dose distribution. The average agreement of EBT3-measured DRC analog is within 3.5% of the TLD-measured DRC analog for all CivaDot sources measured. This agreement is within the overall uncertainty of the measurements using the two dosimeters. This demonstrates the suitability of using EBT3 film as a dosimeter for absolute dose measurements of LDR brachytherapy sources as TLDs are the standard dosimeter of choice for such measurements. Rivard 15 reported a DRC analog value of 0.579 cGy h À1 U À1 which is 4.2% different from the DRC analog value determined by this work (0.555 cGy h À1 U À1 ). Potential reasons for disagreement may include differences in the choice of origin and the amount of palladium loading.
A subsequent CivaDot dose distribution measurement was performed using a film stack in a PMMA phantom. EBT3 films were placed at multiple depths in phantom, and measurements were performed for three CivaDot sources. As measurements closer to the source are prone to errors and increased uncertainty, film measurements shallower than 1 cm were not performed. Overall good agreement was observed between EBT3-measured and MC-predicted distributions using dose difference maps. The results presented in Fig. 6 demonstrate symmetry in source emission across the two axes compared to conventional LDR sources, which may have pronounced anisotropy. Radial dose function analog and two-dimensional anisotropy function analog were also investigated. At depths of 1, 2, 3 cm good agreement was observed for the radial dose function with a slight divergence at deeper depths (4 and 5 cm). The absolute dose delivered at depths (4 and 5 cm) for a measurement is very small (≤1.5%) compared to the dose prescribed at 1 cm depth, and hence, the measurement uncertainty is much larger. Similar results were seen by Reed et al. 4 when measuring the RDF for a conventional 103 Pd brachytherapy seed and comparing measurements to Monte Carlo data. Rivard's 15 reported RDF analog were in good agreement with the MC RDF analog-predicted values. The measured two-dimensional anisotropy function analog agreed to within 6.5% of the MC-predicted values for distances up to 3 cm and within 28% for distances of 4 and 5 cm. Potential reasons for increased divergence at deeper depths may include the fact that absolute doses were very small at these depths and variation due to palladium loading for the two-dimensional anisotropy function determined by MC can vary as much as 25% at these depths. The limited anisotropy data reported are due to the measurement setup geometry, which is more suitable for a rectangular dosimetric formalism coordinate system. Formulating and proposing an alternative dosimetric formalism instead of an adapted TG-43 formalism can be further researched. A point to consider while using the dosimetric data for clinical purposes is that only the gold shield present in a given CivaDot is visible under computer tomography (CT) imaging; hence, it is up to the user to plan accordingly for the post-implant dosimetry, and if possible apply a shift (0.125 mm is the distance from the center of the gold shield to the source origin) to calculate dose more accurately.
Cohen et al. 16 performed an in-phantom measurement using EBT3 film to evaluate the appropriateness of Rivard's results for clinical commissioning of the CivaSheet using relative dosimetry. The dosimetric characterization of a CivaDot as performed in this work will assist in the assessment of the absolute dose distribution of a CivaSheet which is an array of CivaDots.
CONCLUSION
Primary S K measurements of the CivaDot were successfully performed using two different free-air chambers. The investigation assisted in the establishment of a source strength standard for the CivaDot. Dose distribution measurements of the CivaDot performed using TLD microcubes and EBT3 films in a PMMA phantom demonstrated good overall agreement with Monte Carlo-predicted dose distributions, given the uncertainties. The presence of gold shield x-ray fluorescence was observed in the source energy spectrum and its impact on various aspects of this investigation was evaluated. This work will aid in the eventual realization of a clinically viable dosimetric framework for the CivaSheet by testing the feasibility of using the superposition of an adapted TG-43 dosimetric formalism for a CivaDot.
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